T-Cell Leukemia Global Clinical Trials Review, H1, 2014

Date: May 21, 2014
Pages: 125
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T190EED3CBCEN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2014' provides data on the T-Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
T-Cell Leukemia
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of T-Cell Leukemia
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in T-Cell Leukemia Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on T-Cell Leukemia
Aug 23, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase II Trial Of Mogamulizumab In Patients With Adult T-Cell Leukemia-Lymphoma In US And Europe
Apr 09, 2012: Study Demonstrates Potential Of New Anti-Leukemia Compound, Lenaldekar
Jan 25, 2012: Study Shows Leukemia Drug Kills Cancerous T-cells While Sparing Normal Immunity
Dec 07, 2010: Kyowa Hakko Kirin Announces Results From Japan Phase II Clinical Trial Of KW-0761 In Adult T-Cell Leukemia-Lymphoma
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Kirin Holdings Company, Limited
Clinical Trial Overview of Kirin Holdings Company, Limited
BioCryst Pharmaceuticals, Inc.
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Otsuka Holdings Co., Ltd.
Clinical Trial Overview of Otsuka Holdings Co., Ltd.
Novartis AG
Clinical Trial Overview of Novartis AG
Mundipharma International Limited
Clinical Trial Overview of Mundipharma International Limited
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Angimmune LLC
Clinical Trial Overview of Angimmune LLC
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Ministry of Health, Labour and Welfare, Japan
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan
University of Washington
Clinical Trial Overview of University of Washington
Japan Clinical Oncology Group
Clinical Trial Overview of Japan Clinical Oncology Group
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Thomas Jefferson University
Clinical Trial Overview of Thomas Jefferson University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014*
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014*
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
T-Cell Leukemia Therapeutics, Global, Suspended Clinical Trials, 2014*
T-Cell Leukemia Therapeutics, Global, Terminated Clinical Trials, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Angimmune LLC, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*

LIST OF FIGURES

T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014*
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014*
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
GlobalData Methodology
Skip to top


Ask Your Question

T-Cell Leukemia Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: